Kinetics of hemopoietic recovery after peripheral blood stem cell transplantation: Impact of stem cell purification and G-CSF

American Journal of Hematology

Volumn 69, Issue 1, 2002, Pages 7-14

  Piccirillo, Nicola ^a,b   Sor, Federica ^a   Laurenti, Luca ^a   Chiusolo, Patrizia ^a   Serafini, Riccardo ^a   Cicconi, Silvia ^a   Leone, Giuseppe ^a   Sica, Simona ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

CD34+ PBSCT; EPO serum level; G CSF; Hemopoietic recovery; Purging

Indexed keywords

BUSULFAN; CARBOPLATIN; CARMUSTINE; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISONE; THIOTEPA; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; AUTOTRANSPLANTATION; CELL ISOLATION; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEMATOPOIESIS; HODGKIN DISEASE; HUMAN; HUMAN CELL; KINETICS; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PURIFICATION; RETICULOCYTE; STEM CELL TRANSPLANTATION; THROMBOCYTE;

ADOLESCENT; ADULT; ANTIGENS, CD34; CELL SEPARATION; ERYTHROPOIETIN; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HODGKIN DISEASE; HUMANS; KINETICS; LEUKOCYTE COUNT; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEUTROPHILS; PLATELET COUNT; RETICULOCYTE COUNT; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 0036134308     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10016     Document Type: Article

References (30)

1. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants
2. Comparison of hemopoietic and immune recovery after autologous bone marrow or blood stem cell transplants
3. Randomized study of growth factors post-peripheral-blood stem-cell transplant: Neutrophil recovery is improved with modest clinical benefit
4. G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: Results of a randomized BNLI trial
5. + immunoselected peripheral blood progenitor cell transplantation
6. Early infectious complications in autologous bone marrow transplantation: A review of 219 patients
7. Blood and marrow transplantation activity in Europe 1997
8. Peripheral blood progenitor cell transplantation: A replacement for marrow auto- or allografts
9. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment
10. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy
11. Factors that influence collection and engraftment of autologous peripheral-blood stem cells
12. Effect of granulocyte-colony stimulating factor on haematopoietic recovery after peripheral blood progenitor cell transplantation
13. Granulocyte-colony stimulating factor following peripheral-blood progenitor-cell transplant in non Hodgkin's lymphoma
14. Granulocyte-colony stimulating factors accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: A prospective randomized trial
15. Low-dose Filgrastim significantly enhances neutrophil recovery following peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: Evidence for clinical and economic benefit
16. G-CSF administration after peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: Evidence for clinical benefits and reduction of treatment costs
17. G-CSF after PBSC transplantation
18. Delayed G-CSF after autologous progenitor cell transplantation: A prospective randomized trial
19. Is filgrastim as useless after peripheral blood stem cell transplantation for adults as it could be for children?
20. Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation
21. Administration of G-CSF can be delayed after transplantation of autologous G-CSF-primed blood stem cells: A randomized study
22. Delayed G-CSF after autologous bone marrow transplantation
23. Delaying treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for haematological malignancies: A prospective randomized trial
24. Serum erythropoietin levels in patients undergoing autologous bone marrow transplantation
25. Circulating erythropoietin levels after bone marrow transplantation: Inappropriate response to anemia in allogeneic transplants
26. Serum erythropoietin changes in autologous and allogeneic bone marrow transplant patients
27. + peripheral blood stem cells: Retained engraftment capability and reduced tumour cell content
28. High CD34(+) cell counts decrease haematologic toxicity of autologous peripheral blood progenitor cell transplantation
29. + cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation
30. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy